miR-454-3p通过负面调节JARID2驱动肝硬化症的发展
Ting Zhang1, Ziyan Pan1, Lijun Fan1
1Medical College of Shihezi University, Bei-Er-Lu, Shihezi, Xinjiang 832000, China; Key Laboratory of Xinjiang Endemic and Ethic Diseases, Shihezi University, Shihezi, Xinjiang 832000, China.
Biochemical pharmacology
|March 7, 2026
概括
微RNA-454-3p在与代谢功能障碍相关的脂肪性肝病 (MASLD) 中促进肝脂肪的积累. 针对miR-454-3p/JARID2通路可能为MASLD提供治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 代谢疾病 代谢疾病
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 涉及过度的肝脂肪积累.
- 以前的研究将miR-454-3p与2型糖尿病 (T2DM) 和糖解调节联系起来.
研究的目的:
- 在MASLD模型中研究miR-454-3p在调节肝脂代谢中的作用.
- 确定 miR-454-3p 对肝脏脂质积累的影响背后的分子机制.
主要方法:
- 在用自由脂肪酸 (FFA) 治疗的MASLD患者和细胞模型中评估miR-454-3p表达.
- 使用双 luciferase 报告器和 RNA 免疫沉降 (RIP) 测试来确定 miR-454-3p 的目标.
- 使用肝细胞细胞系进行了体外研究,并使用高脂肪饮食 (HFD) 养的小鼠进行了体内实验.
主要成果:
- 在MASLD患者和FFA治疗肝细胞中,miR-454-3p的表达显著升高.
- miR-454-3p直接准并降低含有2 (JARID2) mRNA的Jumonji和AT丰富的相互作用域.
- 过度表达miR-454-3p增强了肝脂发生,这种效应被JARID2联合表达逆转.
- 肝脏中断miR-454-3p减少了肝脏脂肪积累,并改善了HFD养小鼠的MASLD.
结论:
- 在MASLD中,miR-454-3p/JARID2轴是肝脂代谢的关键调节器.
- miR-454-3p促进脂质的合成和在肝脏中的积累.
- 针对miR-454-3p/JARID2通路为MASLD.提供了一个潜在的治疗途径.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
6.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.1K
Liver Regeneration
4.6K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.6K
Hepatic Portal System
7.1K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
7.1K
Hepatic Drug Excretion: Influencing Factors
691
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
691
Lipid Catabolism
1.3K
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.3K
The JAK-STAT Signaling Pathway
13.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.5K


